Abstract
Purpose
Liver fibrosis is considered as one of the ultimate outcomes of chronic liver disorders, characterized by outrageous cell proliferation and abnormal deposition of extracellular matrix, resulting in sever pathological distortions in the architecture and performance of liver tissues. The present study aimed to investigate the protective properties of aqueous methanol extract of Acrocarpus fraxinifolius leaves (AFL) against liver fibrosis induced by dual toxicity of γ-irradiation and carbon tetrachloride (CCl4) in rats.
Methods
The animals were exposed to 2 Gy irradiation once/week concurrently with intraperitoneal administration of CCl4 (0.2 mL/100 g body weight) for seven weeks. Afterwards, liver toxicity and fibrosis were assessed biochemically at cellular and molecular as well as histopathological levels.
Results
The livers of intoxicated rats showed distinct structural and functional changes, compared with the normal rats. The administration of AFL (500 mg/kg, p.o) significantly ameliorated the histopathological manifestations of fibrotic liver evidenced by mitigated steatosis progression, necrosis, fibrotic septa, apoptotic bodies, and immunochistochemical studies of alpha-smooth muscle actin. Also, AFL increased the final body weight, total protein, albumin levels and albumin/globulin ratio. While, the absolute liver weight, liver enzymes, total cholesterol and triglycerides were reduced. A significant modulation was observed in hydroxyproline, transforming growth factor-β and collagen-1expression. Furthermore, AFL exerted a direct effect on liver fibrosis by promoting extracellular matrix degradation via overexpression of the tissue inhibitor metalloproteinase-1, coupled with decease of metalloproteinase-9 activity.
Conclusions
Our findings suggested that AFL effectively improved the architecture of fibrotic liver and modified the biochemical markers of liver fibrosis.
Graphical Abstract
![](/cms/asset/746d1a1b-b4e0-41e2-b4e8-0177737b6131/irab_a_2087926_uf0001_c.jpg)
Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
Notes on contributors
Omama E. El-Shawi
Omama E. El-Shawi, PhD, is a professor of biochemistry at Health Radiation Research Department, National Center for Radiation Research and Technology, Atomic Energy Authority, Cairo, Egypt.
Heba A. S. El-Nashar
Heba A. S. El-Nashar, PhD, is an assistant professor of pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo, Egypt and a researcher at Drug Discovery Research and Development center, Ain Shams University, Egypt.
Sahar S. Abd El-Rahman
Sahar S. Abd El-Rahman, PhD, is an associate professor of pathology, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt.
Omayma A. Eldahshan
Omayma A. Eldahshan, PhD, is a professor of pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo, Egypt and a member of foundation committee of Drug Discovery Research and Development center, Ain Shams University, Egypt.
Abdel Nasser B. Singab
Abdel Nasser B. Singab, PhD, is a professor of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo, Egypt and Chief Executive Officer (CEO) of Drug Discovery Research and Development center, Ain Shams University, Egypt.